Skip to main content
Figure 1 | Critical Care

Figure 1

From: Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial

Figure 1

Correlation between long-term Barthel Index <35 and clinical outcome. Receiver operating characteristics (ROC) curve analysis revealed long-term Barthel Index <35 was the most powerful predictor of long-term major adverse neurological event with a sensitivity of 93.8% and a specificity of 72.7%, P <0.001. AUC, area under the curve.

Back to article page